BAFNAPH
Invest Now
Bafna Pharmaceuticals Share Price
₹78.02 -1.98 (-2.48%)
21 Nov, 2024 14:29
Start SIP in BAFNAPH
Start SIPPerformance
- Low
- ₹78
- High
- ₹80
- 52 Week Low
- ₹73
- 52 Week High
- ₹113
- Open Price₹80
- Previous Close₹80
- Volume33
Investment Returns
- Over 1 Month -3.16%
- Over 3 Month -2.57%
- Over 6 Month -21.67%
- Over 1 Year -10.42%
Smart Investing Starts Here Start SIP with Bafna Pharmaceuticals for Steady Growth!
Bafna Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 453.7
- PEG Ratio
- -4.6
- Market Cap Cr
- 185
- P/B Ratio
- 2.3
- Average True Range
- 3.27
- EPS
- 0.32
- Dividend Yield
- 0
- MACD Signal
- -0.32
- RSI
- 48.3
- MFI
- 64.41
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Technicals
EMA & SMA
Current Price
₹78.02
-1.98
(-2.48%)
- Bullish Moving Average 0
- Bearish Moving Average 16
- 20 Day
- ₹80.42
- 50 Day
- ₹81.22
- 100 Day
- ₹82.89
- 200 Day
- ₹85.92
Resistance and Support
80.67
- R3 83.33
- R2 82.67
- R1 81.33
- S1 79.33
- S2 78.67
- S3 77.33
Bafna Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-29 | Audited Results | |
2024-02-12 | Quarterly Results | |
2023-11-09 | Quarterly Results |
Bafna Pharmaceuticals F&O
About Bafna Pharmaceuticals
- NSE Symbol
- BAFNAPH
- BSE Symbol
- 532989
- ISIN
- INE878I01022
Similar Stocks to Bafna Pharmaceuticals
Bafna Pharmaceuticals FAQs
Bafna Pharmaceuticals share price is ₹78 As on 21 November, 2024 | 14:15
The Market Cap of Bafna Pharmaceuticals is ₹184.6 Cr As on 21 November, 2024 | 14:15
The P/E ratio of Bafna Pharmaceuticals is 453.7 As on 21 November, 2024 | 14:15
The PB ratio of Bafna Pharmaceuticals is 2.3 As on 21 November, 2024 | 14:15
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.